Opportunity Information: Apply for CDC RFA OE12 120203CONT14
Apply for CDC RFA OE12 120203CONT14
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "BioSense 2.0 Building State, Local, Tribal, and Territorial Surveillance Capacity to Enhance Regional and National All Hazards Public Health Situation Awareness Center for Surveillance, Epidemiology and Laboratory Services" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Mar 24, 2014 and posted on Mar 18, 2014.
- Applicants must submit their applications by Apr 30, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 50 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This award will be a continuation of funds intended only for grantees previously awarded under CDC RFA OE 12 1203 Provider Education and Public Awareness about Primary Immunodeficiency Disease.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The BioSense 2.0 initiative focuses on strengthening surveillance capabilities at state, local, tribal, and territorial levels to improve public health awareness about all types of hazards. It emphasizes building a comprehensive system for monitoring health threats and enhancing collaboration among health organizations.
A key aspect of this grant opportunity is educating providers and raising public awareness about Primary Immunodeficiency Disease (PID). This involves developing resources and initiatives aimed at informing healthcare professionals and the community about the signs, symptoms, and importance of recognizing and diagnosing PID. By bolstering knowledge and understanding, the goal is to promote better health outcomes and improve responses to public health challenges related to immunodeficiencies.
Frequently Asked Questions (FAQs)
What is the BioSense 2.0 initiative?
BioSense 2.0 is an initiative focused on strengthening surveillance capabilities at the state, local, tribal, and territorial levels. The overall aim is to improve public health awareness across all types of hazards by supporting a more comprehensive approach to monitoring health threats and sharing information.
What is the main purpose of this grant opportunity?
The purpose is to enhance public health surveillance and situational awareness by building stronger monitoring capacity and improving collaboration among health organizations. A highlighted focus area within the opportunity is provider education and public awareness related to Primary Immunodeficiency Disease (PID).
Who is this initiative intended to support?
The initiative is intended to strengthen capabilities at state, local, tribal, and territorial levels. It supports efforts that improve how public health entities and partners detect, monitor, and respond to health threats.
What does "surveillance capabilities" mean in this context?
In this context, surveillance capabilities refer to the ability to monitor and track health threats and hazards in order to improve public health awareness and response. The initiative emphasizes strengthening systems that help identify and understand health events affecting communities.
What kinds of hazards does BioSense 2.0 address?
The initiative is described as covering all types of hazards. This indicates an all-hazards approach to public health monitoring rather than focusing on a single category of threat.
What does the opportunity say about collaboration?
A central theme is enhancing collaboration among health organizations. The intent is to improve coordination and shared awareness so that partners can better understand health threats and respond effectively.
How does Primary Immunodeficiency Disease (PID) fit into this opportunity?
A key aspect of the opportunity is educating providers and raising public awareness about PID. This includes developing resources and initiatives that help healthcare professionals and the community recognize PID, including its signs and symptoms, and understand the importance of identifying and diagnosing it.
What are the expected education and awareness activities related to PID?
Based on the description, activities include developing resources and launching initiatives designed to inform healthcare providers and the public about PID. The emphasis is on improving recognition, understanding signs and symptoms, and reinforcing the importance of timely diagnosis.
Who are the target audiences for the PID education component?
The target audiences explicitly include healthcare professionals (providers) and the broader community (the public). The work is intended to increase knowledge for both groups.
Why is provider education emphasized?
The opportunity highlights provider education because improving provider knowledge about PID recognition and diagnosis is positioned as a way to promote better health outcomes and strengthen responses to public health challenges related to immunodeficiencies.
What outcomes is this opportunity trying to improve?
The stated goals include improving public health awareness, building a comprehensive system for monitoring health threats, enhancing collaboration, promoting better health outcomes, and improving responses to public health challenges related to immunodeficiencies such as PID.
Does the opportunity describe building a system, developing educational materials, or both?
Both. The initiative emphasizes building a comprehensive system for monitoring health threats and enhancing collaboration, while also identifying provider education and public awareness about PID as a key aspect, including developing resources and initiatives.
Is this opportunity limited to a single health condition?
No. The initiative is framed as improving surveillance for all types of hazards. PID is called out as a key educational and awareness focus within the opportunity, but the surveillance emphasis is broader than a single condition.
What does "public health awareness" mean here?
Public health awareness refers to improved understanding and visibility of health threats and hazards across communities and partner organizations, supported by better monitoring and information-sharing. It also includes raising community awareness about PID through targeted education efforts.
How does increasing awareness about PID connect to broader surveillance goals?
The opportunity links awareness and education to better outcomes and improved responses to challenges related to immunodeficiencies. By improving recognition and diagnosis of PID, health systems and communities can be better prepared to address related public health issues as part of broader monitoring and response efforts.
What does the description say about diagnosing PID?
It emphasizes the importance of recognizing and diagnosing PID and supports efforts that inform providers and the public about signs and symptoms, with the goal of improving knowledge and understanding.
Does the provided information specify funding amounts, deadlines, or eligibility requirements?
No. The provided description explains the initiative's focus areas and goals, but it does not include details such as award size, application deadlines, eligibility criteria, or specific submission requirements.
Does the description specify what resources must be created for PID education?
No specific resource types are listed. It broadly references developing resources and initiatives aimed at informing providers and the community about PID, including signs, symptoms, and the importance of recognition and diagnosis.
Does the opportunity mention how success will be measured?
Not in the provided information. The description states intended goals and outcomes, but it does not define evaluation metrics, performance measures, or reporting requirements.
Does the description indicate which health organizations will collaborate?
No. It notes enhancing collaboration among health organizations in general, without naming specific agencies, departments, or partner types.
Browse more opportunities from the same category: Health
Next opportunity: ROSES 2014 Solar System Workings
Previous opportunity: Serve as the U.S. partner within the global STOP TB Partnership and participate in Stop TB Partnership activities
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA OE12 120203CONT14
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA OE12 120203CONT14) also looked into and applied for these:
| Funding Opportunity |
|---|
| Family Planning, Maternal, Neonatal and Child Health (FP/MNCH) Project in Afghanistan Apply for SOL 306 14 00226 Funding Number: SOL 306 14 00226 Agency: Afghanistan USAID Kabul Category: Health Funding Amount: $55,000,000 |
| Global Non Communicable Disease Prevention and Promotion of Health Apply for CDC RFA GH14 1420 Funding Number: CDC RFA GH14 1420 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Human Immunodeficiency Virus (HIV) Prevention Projects for Young Men of Color Who Have Sex with Men (YMSM of Color) and Apply for CDC RFA PS11 111304CONT14 Funding Number: CDC RFA PS11 111304CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Atopic Dermatitis Research Network (ADRN) (U19) Apply for RFA AI 14 033 Funding Number: RFA AI 14 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Translational Research to Help Older Adults Maintain their Health and Independence in the Community (R21) Apply for PA 14 159 Funding Number: PA 14 159 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Translational Research to Help Older Adults Maintain their Health and Independence in the Community (R01) Apply for PA 14 161 Funding Number: PA 14 161 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Girls Education Strengthen Family and Community Support to Orphans and Vulnerable Children Program Apply for RFA 656 14 000001 Funding Number: RFA 656 14 000001 Agency: Mozambique USAID Maputo Category: Health Funding Amount: $15,864,752 |
| Population based HIV Impact Assessments in Resource Constrained Settings under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 1409 Funding Number: CDC RFA GH14 1409 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $25,000,000 |
| Rural Access to Emergency Devices Grant Program Apply for HRSA 14 129 Funding Number: HRSA 14 129 Agency: Health Resources and Services Administration Category: Health Funding Amount: $150,000 |
| Public Access to Defibrillation Demonstration Project Apply for HRSA 14 130 Funding Number: HRSA 14 130 Agency: Health Resources and Services Administration Category: Health Funding Amount: $150,000 |
| Mali High Impact Health Services II Apply for RFA 688 14 000005 Funding Number: RFA 688 14 000005 Agency: Mali USAID Bamako Category: Health Funding Amount: $45,000,000 |
| Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network Leadership Center (UM2) Apply for RFA AR 14 015 Funding Number: RFA AR 14 015 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network Research Sites (UH2/UH3) Apply for RFA AR 14 016 Funding Number: RFA AR 14 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Modeling Immunity for Biodefense (U19) Apply for RFA AI 14 028 Funding Number: RFA AI 14 028 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| CDCs National Undergraduate Student Program A Public Helath Workplace Experience to Increase Student Interest in Public Health Apply for CDC RFA MN11 110104CONT14 Funding Number: CDC RFA MN11 110104CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Building Capacity and Networks to Address Emerging Infectious Diseases in the Americas Apply for CDC RFA CK13 130102CONT14 Funding Number: CDC RFA CK13 130102CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Leveraging a Recovery Act Resource to Accelerate Research on Neurodevelopment (R01) Apply for RFA MH 15 400 Funding Number: RFA MH 15 400 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Provider Education and Public Awareness about Primary Immunodeficiency Disease Apply for CDC RFA OE12 120303CONT14 Funding Number: CDC RFA OE12 120303CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Targeting Latently Infected Cells Without Reactivation (R01) Apply for RFA AI 14 021 Funding Number: RFA AI 14 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Center for HIV, Viral Hepatitis, STD and TB Prevention (NCHHSTP) Apply for CDC RFA PS13 131502CONT14 Funding Number: CDC RFA PS13 131502CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA OE12 120203CONT14", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.